Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Verch

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Bioanalysis|December 23, 2014
Application of quality by design and statistical quality control concepts in immunoassaysThorsten Verch
Bioanalysis|January 19, 2012
Miniaturized immunoassays: moving beyond the microplateThorsten Verch, Ray Bakhtiar
Bioanalysis|November 26, 2016
A semi-universal assay platform to quantitate vaccines with potential applications for biotherapeuticsJeanette Roman, Silikhone Bouaraphan, Thorsten Verch
The AAPS Journal|April 3, 2025
Application of DOE to ELISA Robustness and Ruggedness AssessmentThy Follmer, Seth Clark, Thorsten Verch
Infection and Immunity|October 27, 2004
Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other bacterial vectors and DNA vaccinesThorsten Verch, Zhen-Kun Pan, Yvonne Paterson
Analytical and Bioanalytical Chemistry|April 27, 2016
Mitigation of microtiter plate positioning effects using a block randomization schemeChristopher Roselle, Thorsten Verch, Mary Shank-Retzlaff
Bioanalysis|June 18, 2016
Reduction of dilution error in ELISAs using an internal standardThorsten Verch, Christopher Roselle, Mary Shank-Retzlaff
Analytical Chemistry|February 25, 2017
Development and Characterization of an HPV Type-16 Specific Modified DNA Aptamer for the Improvement of Potency AssaysJeremiah J Trausch, Mary Shank-Retzlaff, Thorsten Verch
Bioanalysis|January 16, 2018
Principles of vaccine potency assaysThorsten Verch, Jeremiah J Trausch, Mary Shank-Retzlaff
Expert Opinion on Medical Diagnostics|March 16, 2013
MESOMARK(®) in vitro diagnostic test for mesotheliomaZhong-Qian Li, Thorsten Verch, W Jeffrey Allard
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Bioanalysis|December 23, 2014
Application of quality by design and statistical quality control concepts in immunoassaysThorsten Verch
Bioanalysis|January 19, 2012
Miniaturized immunoassays: moving beyond the microplateThorsten Verch, Ray Bakhtiar
Bioanalysis|November 26, 2016
A semi-universal assay platform to quantitate vaccines with potential applications for biotherapeuticsJeanette Roman, Silikhone Bouaraphan, Thorsten Verch
The AAPS Journal|April 3, 2025
Application of DOE to ELISA Robustness and Ruggedness AssessmentThy Follmer, Seth Clark, Thorsten Verch
Infection and Immunity|October 27, 2004
Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other bacterial vectors and DNA vaccinesThorsten Verch, Zhen-Kun Pan, Yvonne Paterson
Analytical and Bioanalytical Chemistry|April 27, 2016
Mitigation of microtiter plate positioning effects using a block randomization schemeChristopher Roselle, Thorsten Verch, Mary Shank-Retzlaff
Bioanalysis|June 18, 2016
Reduction of dilution error in ELISAs using an internal standardThorsten Verch, Christopher Roselle, Mary Shank-Retzlaff
Analytical Chemistry|February 25, 2017
Development and Characterization of an HPV Type-16 Specific Modified DNA Aptamer for the Improvement of Potency AssaysJeremiah J Trausch, Mary Shank-Retzlaff, Thorsten Verch
Bioanalysis|January 16, 2018
Principles of vaccine potency assaysThorsten Verch, Jeremiah J Trausch, Mary Shank-Retzlaff
Expert Opinion on Medical Diagnostics|March 16, 2013
MESOMARK(®) in vitro diagnostic test for mesotheliomaZhong-Qian Li, Thorsten Verch, W Jeffrey Allard
Pageof 4